S

Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399

Watchlist Manager
Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399
Watchlist
Price: 11.07 CNY -2.47%
Market Cap: 13.8B CNY
Have any thoughts about
Shenzhen Hepalink Pharmaceutical Group Co Ltd?
Write Note

Net Margin
Shenzhen Hepalink Pharmaceutical Group Co Ltd

-4.4%
Current
3%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-4.4%
=
Net Income
-242.9m
/
Revenue
5.6B

Net Margin Across Competitors

Country CN
Market Cap 13.8B CNY
Net Margin
-4%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 793.7B USD
Net Margin
19%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country DK
Market Cap 3.4T DKK
Net Margin
35%
Country US
Market Cap 385.5B USD
Net Margin
17%
Country US
Market Cap 260.6B USD
Net Margin
22%
Country CH
Market Cap 213.6B CHF
Net Margin
20%
Country UK
Market Cap 171.2B GBP
Net Margin
13%
Country CH
Market Cap 183.5B CHF
Net Margin
33%
Country US
Market Cap 160.4B USD
Net Margin
7%

Profitability Report

View the profitability report to see the full profitability analysis for Shenzhen Hepalink Pharmaceutical Group Co Ltd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-4.4%
=
Net Income
-242.9m
/
Revenue
5.6B
What is the Net Margin of Shenzhen Hepalink Pharmaceutical Group Co Ltd?

Based on Shenzhen Hepalink Pharmaceutical Group Co Ltd's most recent financial statements, the company has Net Margin of -4.4%.